Durvalumab: NICE recommends new lung cancer treatment
New drug is 'biggest advance' seen for some time in treating certain lung cancers
15 Jun 2019
Clinical update
Biosimilars: a snapshot of latest developments
Biosimilars are biological drugs that reproduce the effects of more expensive drugs
10 Apr 2019
Combination therapy for untreated, metastatic, non-squamous non-small-cell lung cancer
NICE recommends use of pembrolizumab with pemetrexed and platinum chemotherapy
06 Dec 2018
Alternative therapy to be offered for people with large-cell lymphoma
NICE offers alternative therapy for those diagnosed with lymphoma
28 Nov 2018
NICE recommends drug to treat rare form of cancer
National Institute for Health and Care Excellence proposes drug for high-risk neuroblastoma
08 Aug 2018
Thyroid cancer treatment recommended by NICE
New guidance by The National Institute for Health and Care Excellence sets out...
26 Apr 2018
Pain management in children
Summary and nursing implications of the latest updates to clinical practice.
20 Apr 2018
New drug therapy for myeloma
A collaboration between Cancer Drugs Fund and National Institute for Health and Care...
16 Feb 2018
New drug available for head and neck cancer patients not responding to chemotherapy
The National Institute for Health and Care Excellence recommends nivolumab is made available...
24 Nov 2017
Kidney cancer
The National Institute for Health and Care Excellence has helped people with advanced kidney...
22 Sep 2017
Screening and management of long-term consequences of myeloma and its treatment
Life expectancy rates for patients who have myeloma, which affects areas of the body where...
21 Feb 2017
Infusion therapy
Ensuring the safest care for patients undergoing infusion therapy through updated guidance
24 Jan 2017
Non-Hodgkin’s lymphoma
Your essential guide to signs, symptoms, treatment and the latest guidelines on Non-Hodgkin'...
11 Aug 2016
Clinical update: Treating breast cancer
What you need to know about treating breast cancer
05 Jul 2016